Sabine Strommer - Concepedia

Author

Sabine Strommer

Medical University of Vienna

Also Known As

S Strommer, S. Strommer, Sabine Strommer

Publications

908

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna University of Vienna Austrian Institute of Technology University of Veterinary Medicine Vienna Ludwig Boltzmann Institute for Cardiovascular Research

About

Sabine Strommer is an author at Medical University of Vienna specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	558
2	Cell Biology	5	5	373
3	Immunology	2	2	75
4	Microbiology	2	2	44
5	Allergy	1	1	26

Sabine Strommer

Publications

894

Citations

H-Index

Page 1

	Year	Citations
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy Wolfgang Sieghart, Doris Losert, Sabine Strommer, Journal of Hepatology Tumor BiologyMedicineMcl-1 OverexpressionPathologyAntisense Therapy	2005	251
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo Daniel Cejka, Matthias Preusser, Adelheid Wöehrer, Cancer Biology & Therapy	2008	71
Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo Johannes Werzowa, Stefan Koehrer, Sabine Strommer, Journal of Investigative Dermatology Cell SignalingMedicineMelanomaImmune Checkpoint InhibitorVertical Inhibition	2010	50
Inflammatory Skin Disease in K14/p40 Transgenic Mice: Evidence for Interleukin-12-Like Activities of p40 Tamara Kopp, J. David Kieffer, Antal Rot, Journal of Investigative Dermatology InflammationK14/p40 Transgenic MiceCytokineAutoimmune DiseaseCutaneous Biology	2001	49
mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo Thorsten Fuereder, Agnes Jaeger-Lansky, Doris Hoeflmayer, Cancer Letters MedicinePharmacologyGastric CancerAnti-cancer AgentCancer Treatment	2010	44
Effect of Pulmonary Surfactant on Antimicrobial Activity <i>In Vitro</i> Richard Schwameis, Zeynep Erdogan-Yildirim, Mohammad Manafi, Antimicrobial Agents and Chemotherapy	2013	42
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo Daniel Cejka, Claudia Kuntner, Matthias Preusser, British Journal of Cancer	2009	39
Colistin Reduces LPS‐Triggered Inflammation in a Human Sepsis Model <i>In Vivo:</i> A Randomized Controlled Trial Peter Matzneller, Sabine Strommer, Christa Drucker, Clinical Pharmacology & Therapeutics	2016	35
Gastric Cancer Growth Control by BEZ235 <i>In Vivo</i> Does Not Correlate with PI3K/mTOR Target Inhibition but with [18F]FLT Uptake Thorsten Fuereder, Thomas Wanek, Pamina Pflegerl, Clinical Cancer Research	2011	33
Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID Mice Volker Wacheck, Clemens Krepler, Sabine Strommer, Antisense and Nucleic Acid Drug Development	2002	31

Page 1